First‐line treatment in Parkinson's disease

E-ISSN： 1474-7766|5|3|160-167

ISSN： 1474-7758

Source： PRACTICAL NEUROLOGY, Vol.5, Iss.3, 2005-06, pp. : 160-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Parkinson's Disease: The Treatment Options.

By Bain P.G.

Brain, Vol. 123, Iss. 3, 2000-03 ,pp. : 651-652

Oxford University Press

Access to resources Recommend Favorite

Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease

By Lapchak P.A. Gash D.M. Collins F. Hilt D. Miller P.J. Araujo D.M.

Experimental Neurology, Vol. 145, Iss. 2, 1997-06 ,pp. : 309-321

Elsevier

Access to resources Recommend Favorite

Neural transplantation for the treatment of Parkinson's disease

By Bjorklund A. Dunnett S.B. Brundin P. Stoessl A.J. Freed C.R. Breeze R.E. Levivier M. Peschanski M. Studer L. Barker R.

Lancet Neurology, Vol. 2, Iss. 7, 2003-07 ,pp. : 437-445

Elsevier

Access to resources Recommend Favorite

The potential of GDNF as a treatment for Parkinson's disease

By Hurelbrink C.B. Barker R.A.

Experimental Neurology, Vol. 185, Iss. 1, 2004-01 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

New treatment of depression in Parkinson's disease

By Maruyama Tetsuhiro

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 1, 2003-01 ,pp. : 25-27

Ashgate Publishing Ltd

Access to resources Recommend Favorite